Cargando…
Serology for Trachoma Surveillance after Cessation of Mass Drug Administration
BACKGROUND: Trachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious cause of blindness worldwide. Yearly azithromycin mass drug administration (MDA) plays a central role in efforts to eliminate blinding trachoma as a public health problem. Programmatic decision-making is currently...
Autores principales: | Martin, Diana L., Bid, Rhiannon, Sandi, Frank, Goodhew, E. Brook, Massae, Patrick A., Lasway, Augustin, Philippin, Heiko, Makupa, William, Molina, Sandra, Holland, Martin J., Mabey, David C. W., Drakeley, Chris, Lammie, Patrick J., Solomon, Anthony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340913/ https://www.ncbi.nlm.nih.gov/pubmed/25714363 http://dx.doi.org/10.1371/journal.pntd.0003555 |
Ejemplares similares
-
The utility of serology for elimination surveillance of trachoma
por: Pinsent, Amy, et al.
Publicado: (2018) -
Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015) -
CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012) -
Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023) -
In Vivo Confocal Microscopy in Scarring Trachoma
por: Hu, Victor H., et al.
Publicado: (2011)